CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Dec. 31, 2025	Dec. 31, 2024
ASSETS:
Cash and due from banks		$ 1,464	$ 1,409
Interest-bearing cash and due from banks		11,263	9,192
Interest-bearing deposits in banks	[1]	961	635
Debt securities available for sale, at fair value (including $108 and $152 pledged to creditors, respectively)	[2]	35,697	32,765
Debt securities held to maturity (fair value of $7,150 and $7,540, respectively, and including $67 and $83 pledged to creditors, respectively)	[2]	7,933	8,599
Loans held for sale (includes $1,065 and $825, respectively, measured at fair value)		1,198	858
Loans and leases		142,692	139,203
Less: Allowance for loan and lease losses		(1,943)	(2,061)
Net loans and leases	[1]	140,749	137,142
Premises and equipment, net		915	875
Bank-owned life insurance		3,441	3,364
Goodwill		8,187	8,187
Other intangible assets	[3]	115	146
Other assets	[1],[4]	14,428	14,349
TOTAL ASSETS		226,351	217,521
Deposits:
Noninterest-bearing		40,417	36,920
Interest-bearing		142,896	137,856
Total deposits		183,313	174,776
Short-term borrowed funds		58	0
Long-term borrowed funds	[1]	11,224	12,401
Other liabilities	[1],[4]	5,439	6,090
TOTAL LIABILITIES		200,034	193,267
Commitments and Contingencies (refer to Note 17)
Preferred Stock:
$25.00 par value,100,000,000 shares authorized; 2,150,000 shares issued and outstanding at December 31, 2025 and 2024		2,111	2,113
Common stock:
$0.01 par value, 1,000,000,000 shares authorized; 652,238,745 shares issued and 429,242,174 shares outstanding at December 31, 2025 and 650,068,324 shares issued and 440,543,381 shares outstanding at December 31, 2024		7	7
Additional paid-in capital		22,476	22,364
Retained earnings		11,345	10,412
Treasury stock, at cost, 222,996,571 and 209,524,943 shares at December 31, 2025 and 2024, respectively		(7,652)	(7,047)
Accumulated other comprehensive income (loss)		(1,970)	(3,595)
TOTAL STOCKHOLDERS’ EQUITY		26,317	24,254
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		$ 226,351	$ 217,521

[1] Includes amounts in consolidated VIEs. See Note 9 for additional information.

[2] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.

[3] Excludes MSRs, which are reported in Other assets.

[4] See Note 1 for information regarding updates to the Consolidated Balance Sheets during 2025.